Delivery Order SPE2DX22D0129-SPE2D826F0BUD
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $31,361.72 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $47,477.79 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products to support federal medical procurement needs. The contract was awarded to AmerisourceBergen's Corporate Office...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,373.38 to AmerisourceBergen Drug Corp on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,200.54 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies and pharmaceuticals needed to support federal healthcare operations. The order will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply delivery to support federal military and healthcare systems. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $113,624 to AmerisourceBergen Drug Corp on December 1, 2025, with completion targeted for December 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The work will be performed at the company's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,005.86 to AmerisourceBergen Drug Corp on November 15, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply deliveries to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,889.23 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,309.25 to AmerisourceBergen Drug Corp on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a $39,640.32 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for pharmaceutical and medical supply products. The contract is structured as a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. The order is set to be completed by December 3, 2025, and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0BUDDelivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $75,646.20 to AmerisourceBergen Drug Corp on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply deliveries. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and related supplies—to support military healthcare programs and other federal medical systems worldwide. AmerisourceBergen's position as a major pharmaceutical distributor and critical vendor for federal medical procurement demonstrates its capability to fulfill complex and varied medical supply requirements across multiple therapeutic domains in support of Defense Department healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.6k | 11/30/25 |